Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maximizing statistical power in group-randomized vaccine trials.

T Riggs1, J S Koopman

  • 1Department of Epidemiology, University of Michigan, Ann Arbor, 48109, USA.

Epidemiology and Infection
|November 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamics affecting the risk of silent circulation when oral polio vaccination is stopped.

Epidemics·2017
Same author

Hypertriglyceridemia in extremely low birth weight infants receiving lipid emulsions.

Journal of neonatal-perinatal medicine·2015
Same author

Dynamic Variation in Sexual Contact Rates in a Cohort of HIV-Negative Gay Men.

American journal of epidemiology·2015
Same author

Resuscitation of infants born at 22 weeks gestation: a 20-year retrospective.

Journal of perinatology : official journal of the California Perinatal Association·2012
Same author

Comparison of cardiac Z-score with cardiac asymmetry for prenatal screening of congenital heart disease.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2011
Same author

Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant?

Diseases of the colon and rectum·2010

Statistical power in group-randomized vaccine trials is complex. Serological testing significantly enhances statistical power by differentiating immunity status, improving vaccine trial efficiency.

Area of Science:

  • Epidemiology
  • Biostatistics
  • Immunology

Background:

  • Group-randomized vaccine trials present complex statistical power dynamics.
  • Natural immunity and transmission sources (within vs. outside the group) further complicate power calculations.

Purpose of the Study:

  • To assess the impact of direct agent detection versus serological detection on statistical power in vaccine trials.
  • To evaluate how natural immunity influences statistical power in group-randomized trials.

Main Methods:

  • Developed stochastic compartmental models using differential equations to simulate group dynamics.
  • Contrasted models with varying natural immunity assumptions (absent, affecting susceptible, affecting susceptible and infected).
  • Analyzed effects of endemic infection, transmission origins, vaccine efficacy, and waning rates.

Related Experiment Videos

Main Results:

  • Statistical power is influenced by the proportion of infections originating within versus outside the group.
  • Partial natural immunity complicates power calculations but can be leveraged.
  • Serological testing significantly enhanced statistical power by stratifying individuals based on natural immunity status.

Conclusions:

  • Serological testing offers a significant advantage in enhancing statistical power for group-randomized vaccine trials.
  • Accounting for natural immunity status through serological methods improves the precision of vaccine efficacy assessments.
  • Model simulations provide insights into optimizing vaccine trial design for complex epidemiological scenarios.